FR3035589B1 - Composition pour la protection des cellules de l'epithelium pigmentaire retinien - Google Patents

Composition pour la protection des cellules de l'epithelium pigmentaire retinien Download PDF

Info

Publication number
FR3035589B1
FR3035589B1 FR1553957A FR1553957A FR3035589B1 FR 3035589 B1 FR3035589 B1 FR 3035589B1 FR 1553957 A FR1553957 A FR 1553957A FR 1553957 A FR1553957 A FR 1553957A FR 3035589 B1 FR3035589 B1 FR 3035589B1
Authority
FR
France
Prior art keywords
cells
composition
protection
retinal pigmentary
pigmentary epithelium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1553957A
Other languages
English (en)
French (fr)
Other versions
FR3035589A1 (fr
Inventor
Rene Lafont
Stanislas Veillet
Jose-Alain Sahel
Valerie Fontaine
Pierre-Paul Elena
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sorbonne Universite
Biophytis SA
Original Assignee
Universite Pierre et Marie Curie
Institut Biophytis SAS
Iris Pharma SAS
Sorbonne Universite
Biophytis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1553957A priority Critical patent/FR3035589B1/fr
Application filed by Universite Pierre et Marie Curie, Institut Biophytis SAS, Iris Pharma SAS, Sorbonne Universite, Biophytis SA filed Critical Universite Pierre et Marie Curie
Priority to CA2984405A priority patent/CA2984405C/fr
Priority to AU2016256637A priority patent/AU2016256637A1/en
Priority to BR112017023264-2A priority patent/BR112017023264A2/pt
Priority to RU2017141462A priority patent/RU2715889C2/ru
Priority to CN201680037407.9A priority patent/CN107708685B/zh
Priority to MX2017013918A priority patent/MX376021B/es
Priority to EP16722319.7A priority patent/EP3288551B1/fr
Priority to JP2017556593A priority patent/JP6660401B2/ja
Priority to ES16722319T priority patent/ES2752061T3/es
Priority to PL16722319T priority patent/PL3288551T3/pl
Priority to PCT/FR2016/051001 priority patent/WO2016174360A1/fr
Priority to KR1020177034255A priority patent/KR102575312B1/ko
Priority to US15/570,720 priority patent/US10314804B2/en
Publication of FR3035589A1 publication Critical patent/FR3035589A1/fr
Priority to IL255276A priority patent/IL255276A0/en
Application granted granted Critical
Publication of FR3035589B1 publication Critical patent/FR3035589B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
FR1553957A 2015-04-30 2015-04-30 Composition pour la protection des cellules de l'epithelium pigmentaire retinien Active FR3035589B1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FR1553957A FR3035589B1 (fr) 2015-04-30 2015-04-30 Composition pour la protection des cellules de l'epithelium pigmentaire retinien
PL16722319T PL3288551T3 (pl) 2015-04-30 2016-04-28 Kompozycja zawierająca norbiksynę do ochrony komórek nabłonka barwnikowego siatkówki
BR112017023264-2A BR112017023264A2 (pt) 2015-04-30 2016-04-28 composição
RU2017141462A RU2715889C2 (ru) 2015-04-30 2016-04-28 Композиция, содержащая норбиксин, для защиты клеток пигментного эпителия сетчатки
CN201680037407.9A CN107708685B (zh) 2015-04-30 2016-04-28 含有降胭脂树素的、用于保护视网膜色素上皮细胞的组合物
MX2017013918A MX376021B (es) 2015-04-30 2016-04-28 Composición que contiene norbixina para proteger las células del epitelio de pigmento de la retina.
EP16722319.7A EP3288551B1 (fr) 2015-04-30 2016-04-28 Composition contenant de la norbixine pour la protection des cellules de l'epithelium pigmentaire retinien
JP2017556593A JP6660401B2 (ja) 2015-04-30 2016-04-28 網膜色素上皮の細胞を保護するためのノルビキシン含有組成物
CA2984405A CA2984405C (fr) 2015-04-30 2016-04-28 Composition contenant de la norbixine pour la protection des cellules de l'epithelium pigmentaire retinien
AU2016256637A AU2016256637A1 (en) 2015-04-30 2016-04-28 Composition containing norbixin for protecting cells of the retinal pigment epithelium
PCT/FR2016/051001 WO2016174360A1 (fr) 2015-04-30 2016-04-28 Composition contenant de la norbixine pour la protection des cellules de l'epithelium pigmentaire retinien
KR1020177034255A KR102575312B1 (ko) 2015-04-30 2016-04-28 망막 색소 상피 세포를 보호하기 위한 노르빅신 함유 조성물
US15/570,720 US10314804B2 (en) 2015-04-30 2016-04-28 Composition containing norbixin for protecting cells of the retinal pigment epithelium
ES16722319T ES2752061T3 (es) 2015-04-30 2016-04-28 Composición que contiene norbixina para la protección de las células del epitelio pigmentario retiniano
IL255276A IL255276A0 (en) 2015-04-30 2017-10-26 Composition containing norbixin for protecting cells of the retinal pigment epithelium

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1553957 2015-04-30
FR1553957A FR3035589B1 (fr) 2015-04-30 2015-04-30 Composition pour la protection des cellules de l'epithelium pigmentaire retinien

Publications (2)

Publication Number Publication Date
FR3035589A1 FR3035589A1 (fr) 2016-11-04
FR3035589B1 true FR3035589B1 (fr) 2019-12-13

Family

ID=53758384

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1553957A Active FR3035589B1 (fr) 2015-04-30 2015-04-30 Composition pour la protection des cellules de l'epithelium pigmentaire retinien

Country Status (15)

Country Link
US (1) US10314804B2 (enExample)
EP (1) EP3288551B1 (enExample)
JP (1) JP6660401B2 (enExample)
KR (1) KR102575312B1 (enExample)
CN (1) CN107708685B (enExample)
AU (1) AU2016256637A1 (enExample)
BR (1) BR112017023264A2 (enExample)
CA (1) CA2984405C (enExample)
ES (1) ES2752061T3 (enExample)
FR (1) FR3035589B1 (enExample)
IL (1) IL255276A0 (enExample)
MX (1) MX376021B (enExample)
PL (1) PL3288551T3 (enExample)
RU (1) RU2715889C2 (enExample)
WO (1) WO2016174360A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3078252B1 (fr) * 2018-02-28 2020-08-14 Biophytis Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation
CA3098868A1 (en) 2018-05-03 2019-11-07 L.E.A.F. Holdings Group Llc Carotenoid compositions and uses thereof
KR20200134935A (ko) 2019-05-24 2020-12-02 (주)비지엔케어 커큐민을 유효성분으로 포함하는 인간 망막색소상피세포 증식 개선용 약학 조성물
EP4054637A4 (en) * 2019-11-06 2023-12-20 L.E.A.F Holdings Group LLC CAROTINOID COMPOSITIONS AND USES THEREOF
FR3105790B1 (fr) * 2019-12-26 2022-01-14 Biophytis Composés chimiques ciblant l’œil et leur utilisation dans le traitement de maladies oculaires
KR20210008884A (ko) 2021-01-08 2021-01-25 (주)비지엔케어 커큐민을 유효성분으로 포함하는 인간 망막색소상피세포 증식 개선용 조성물 및 기능성 식품 조성물
TWI894483B (zh) * 2022-08-24 2025-08-21 鼎赫生物科技股份有限公司 一種組合物用於治療眼睛疾病之醫藥品用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1154172A (fr) 1955-07-05 1958-04-03 Rollei Werke Franke Heidecke étui de protection pour appareils photographiques
WO2001085183A2 (en) * 2000-05-08 2001-11-15 N.V. Nutricia Preparation for the prevention and treatment of ocular disorders
CA2528718A1 (en) * 2003-06-20 2004-12-29 Alcon, Inc. Treatment of amd with combination of ingredients
US7887847B2 (en) * 2004-05-08 2011-02-15 Paul Jr Edward L Nutritional supplement for treatment of ocular diseases
EP1814540A2 (en) * 2004-11-16 2007-08-08 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
JP2008179632A (ja) * 2006-12-29 2008-08-07 Fuji Chem Ind Co Ltd 抗酸化剤
JP5550854B2 (ja) * 2009-06-10 2014-07-16 理研ビタミン株式会社 一重項酸素消去剤
FR2947173B1 (fr) 2009-06-25 2012-01-27 Inst Biophytis Composition alimentaire destinee a la protection solaire
JP2012097003A (ja) * 2010-10-29 2012-05-24 Gifu City ビキシン誘導体及び細胞保護剤
FR2975008B1 (fr) * 2011-05-13 2014-03-07 Inst Biophytis Utilisation de composes et composition pour le traitement de la degenerescence maculaire liee a l'age (dmla)

Also Published As

Publication number Publication date
CA2984405C (fr) 2024-01-23
IL255276A0 (en) 2017-12-31
ES2752061T3 (es) 2020-04-02
PL3288551T3 (pl) 2020-04-30
CA2984405A1 (fr) 2016-11-03
JP6660401B2 (ja) 2020-03-11
FR3035589A1 (fr) 2016-11-04
JP2018518460A (ja) 2018-07-12
KR102575312B1 (ko) 2023-09-06
BR112017023264A2 (pt) 2018-08-07
RU2017141462A (ru) 2019-05-31
US20180289651A1 (en) 2018-10-11
MX2017013918A (es) 2018-04-24
AU2016256637A1 (en) 2017-12-14
EP3288551A1 (fr) 2018-03-07
US10314804B2 (en) 2019-06-11
CN107708685B (zh) 2021-09-21
RU2715889C2 (ru) 2020-03-04
EP3288551B1 (fr) 2019-07-31
WO2016174360A9 (fr) 2017-11-16
RU2017141462A3 (enExample) 2019-09-12
CN107708685A (zh) 2018-02-16
WO2016174360A1 (fr) 2016-11-03
KR20180011777A (ko) 2018-02-02
MX376021B (es) 2025-03-07

Similar Documents

Publication Publication Date Title
FR3035589B1 (fr) Composition pour la protection des cellules de l'epithelium pigmentaire retinien
EA201992610A1 (ru) Экспансия -t-клеток, композиции и способы их применения
EA201892147A1 (ru) Бициклические соединения
EA201691514A1 (ru) Соединения
EA201692203A1 (ru) Соединения, ингибирующие tank-связывающую киназу
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
EA201890049A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
EA201492223A1 (ru) Новые диазаспироциклоалканы и азаспироциклоалканы
EA201890048A1 (ru) Композиции, содержащие бактериальные штаммы
PH12018502473B1 (en) Pegylated carfilzomib compounds
EA201590887A1 (ru) Композиция
EA201500943A1 (ru) Составы для мобилизации, хоуминга, размножения и дифференцировки стволовых клеток и способы применения составов
PH12014502624A1 (en) Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
EA201892123A1 (ru) 6-гидрокси-4-оксо-1,4-дигидропиримидин-5-карбоксамиды в качестве агонистов apj
SG10201909805XA (en) Surface modified polymer compositions
EA201891336A1 (ru) Гетероарилгидроксипиримидиноны в качестве агонистов рецептора apj
EA201890572A1 (ru) Биофармацевтические композиции
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
EA201790570A1 (ru) Модуляторы р2х7
EA201990810A1 (ru) Композиция, содержащая соль ацилглутамата в качестве основного поверхностно-активного вещества или основного анионного поверхностно-активного вещества и специфические структурирующие полимеры
MX362919B (es) Moduladores del receptor acoplado a proteína-g 120 (gpr120) de ácido biciclo-[2.2.1].
EA201892500A1 (ru) Применение фракции лигнина в качестве антифитопатогенного агента и содержащие ее антифитопатогенные композиции
MX387591B (es) Compuestos cristalinos
MA39337A1 (fr) Modulateurs de pyrazines de gpr6

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20161104

PLFP Fee payment

Year of fee payment: 3

CD Change of name or company name

Owner name: BIOPHYTIS, FR

Effective date: 20170608

Owner name: UNIVERSITE PARIS 6 PIERRE ET MARIE CURIE, FR

Effective date: 20170608

CJ Change in legal form

Effective date: 20170608

TQ Partial transmission of property

Owner name: BIOPHYTIS, FR

Effective date: 20170608

Owner name: UNIVERSITE PARIS 6 PIERRE ET MARIE CURIE, FR

Effective date: 20170608

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

TQ Partial transmission of property

Owner name: SORBONNE UNIVERSITE, FR

Effective date: 20191120

Owner name: BIOPHYTIS, FR

Effective date: 20191120

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

GC Lien (pledge) constituted

Effective date: 20240808

RG Lien (pledge) cancelled

Effective date: 20250811

GC Lien (pledge) constituted

Effective date: 20250826